$ISIS Recent Headlines Health-care-related stocks keep on

New Post Public Reply Private Reply Replies (0) Message Board

Mar 4, 2014 at 11:19 AM

$ISIS Recent Headlines

Health-care-related stocks keep on giving 12:02 p.m. Feb. 12, 2014 - The Trading Deck
See the future 12:42 p.m. Feb. 3, 2014 - Cody Willard
Charting the S&P 500’s excellent 2013 adventure 11:59 a.m. Dec. 23, 2013 - Michael Ashbaugh
Market technicals tame despite debt-ceiling debate 10:43 a.m. Sept. 25, 2013 - Michael Ashbaugh
Isis reaches a new high on tests for treatment of muscular disorder 2:03 p.m. Sept. 19, 2013 - Russ Britt
Isis, Biogen working on ways to fight disease through gene altering 9:59 a.m. Sept. 9, 2013 - Russ Britt
Isis, Novartis, Halozyme all rise on positive product news 10:48 a.m. Sept. 3, 2013 - Russ Britt
Despite positive tests, investors let some air out of Isis Pharmaceuticals 10:30 a.m. July 22, 2013 - Russ Britt
5 stocks to watch 2:35 p.m. July 11, 2013 - The Trading Deck
Onyx share surge lifts several boats in biotech harbor, including ETFs 10:33 a.m. July 1, 2013 - Russ Britt
S&P’s 50-day average marks the technical test 10:39 a.m. June 27, 2013 - Michael Ashbaugh
After the close: Alexion climbs on FDA news, Biogen basks in glory 4:35 p.m. June 26, 2013 - Russ Britt
After dramatic moves, Isis and Allergan dart in different directions 5:18 p.m. June 25, 2013 - Russ Britt
Dissecting the close: Isis soars on data, while Pfizer loses on spin-off 6:26 p.m. June 24, 2013 - Russ Britt
3 ways to play the biotech boom 6:01 a.m. June 3, 2013 - Jeff Reeves
S&P 500 holds the 50-day average — barely 10:41 a.m. April 18, 2013 - Michael Ashbaugh
Biogen inks drug-development deal with Isis 2:06 p.m. Dec. 10, 2012 - MarketWatch.com
Isis: progress in early-stage study of cancer drug 7:53 a.m. Oct. 31, 2012 - MarketWatch.com
Isis Pharma rises 9% in premarket 6:22 a.m. Oct. 19, 2012 - Steve Gelsi
Investing in ‘junk DNA’ 9:28 p.m. Sept. 11, 2012 - Jen Wieczner

Cramer's Mad Money - Much Ado About Baidu (3/3/14) 6:08 a.m. Today - Seeking Alpha
Jim Cramer's Top Stock Picks: BIDU GNC VSI ISIS 6:00 a.m. Today - TheStreet.com
Jim Cramer's 'Mad Money' Recap: Stop Panicking 8:08 p.m. March 3, 2014 - TheStreet.com
US Stock Futures Tumble Ahead Of Economic Data 6:20 a.m. March 3, 2014 - benzinga.com
10-K: ISIS PHARMACEUTICALS INC 6:06 a.m. March 3, 2014 - Edgar Online - (EDG = 10Q, 10K)
Isis' CEO Discusses Q4 2013 Results - Earnings Call Transcript 5:32 p.m. Feb. 28, 2014 - Seeking Alpha
Isis Pharmaceuticals (ISIS) Is Water-Logged And Getting Wetter Today 2:29 p.m. Feb. 28, 2014 - TheStreet.com
3 Stocks Pulling The Health Care Sector Downward 12:02 p.m. Feb. 28, 2014 - TheStreet.com
Silence Therapeutics A Quieter Name In RNAi 6:38 p.m. Feb. 27, 2014 - Seeking Alpha
Biotech Stock Roundup: Isis Soars on Positive Data, Onconova Falls - Analyst Blog 10:26 a.m. Feb. 26, 2014 - Zacks.com
Growth Stocks: 7 Rallying Stocks With No Profits (Yeta????) 5:51 p.m. Feb. 24, 2014 - TheStreet.com
Isis Pharma Soars on Positive Data - Analyst Blog 1:30 p.m. Feb. 24, 2014 - Zacks.com
ISIS reiterated a Buy at Deutsche after data 11:03 a.m. Feb. 21, 2014 - Seeking Alpha
Isis therapy for spinal muscular atrophy provides encouraging results 7:41 a.m. Feb. 21, 2014 - Seeking Alpha
Isis Pharmaceuticals (ISIS): Today's Featured Drugs Laggard 5:01 p.m. Feb. 18, 2014 - TheStreet.com
Positive Opinion on Isis Pharma's ISIS-TTRRx - Analyst Blog 11:50 a.m. Feb. 18, 2014 - Zacks.com
Isis to get another $9M from Biogen 9:15 a.m. Feb. 13, 2014 - Seeking Alpha
Canadian Nod for Aegerion's Juxtapid - Analyst Blog 4:45 p.m. Feb. 11, 2014 - Zacks.com
OncoGenex Has A Potential Blockbuster Drug, But The Markets Are Pricing It Like An Orphan 9:25 a.m. Jan. 28, 2014 - Seeking Alpha
Jim Cramer's Top Stock Picks: ISIS JAZZ SYY ETH IBM 6:00 a.m. Jan. 28, 2014 - TheStreet.com

Isis Reports Financial Results And Highlights For 2013 8:30 a.m. Feb. 28, 2014 - PR Newswire - PRF
Isis Pharmaceuticals to Present at the Cowen 34th Annual Health Care Conference 7:00 a.m. Feb. 25, 2014 - PR Newswire - PRF
Critical Alerts For Cisco Systems, Michael Kors, Whole Foods Market, MetLife, and Isis Pharmaceuticals Released By InvestorsObserver 9:31 a.m. Feb. 24, 2014 - PR Newswire - PRF
Brookdale Senior Living hits 5 year high on Emeritus Acquistion; eBay acquires PhiSix 12:26 a.m. Feb. 24, 2014 - ACCESSWIRE
Isis Pharmaceuticals Reports Interim Results from ISIS-SMN Rx Phase 2 Study in Infants with Spinal Muscular Atrophy 5:00 p.m. Feb. 21, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Reports Interim Results from ISIS-SMN Rx Multiple Dose Study in Children with Spinal Muscular Atrophy 7:00 a.m. Feb. 21, 2014 - PR Newswire - PRF
Webcast Alert: Isis Pharmaceuticals' 2013 Financial Results and Highlights Conference Call 5:01 p.m. Feb. 20, 2014 - PR Newswire - PRF
Isis Pharmaceuticals to Present at the 2014 RBC Capital Markets Global Healthcare Conference 7:00 a.m. Feb. 19, 2014 - PR Newswire - PRF
Isis Announces Positive Opinion on European Orphan Drug Designation for ISIS-TTR Rx 1:32 p.m. Feb. 14, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Advances ISIS-SMN Rx in Infants and Children with Spinal Muscular Atrophy 7:00 a.m. Feb. 13, 2014 - PR Newswire - PRF
Isis Pharmaceuticals to Present at the Leerink Global Healthcare Conference 7:00 a.m. Feb. 6, 2014 - PR Newswire - PRF
Joseph Loscalzo, M.D., Ph.D., Joins Isis Pharmaceuticals' Board of Directors 2:47 p.m. Feb. 3, 2014 - PR Newswire - PRF
RXI Pharmaceuticals Could Benefit from Biotech Industry Dynamics 10:06 a.m. Jan. 24, 2014 - ACCESSWIRE
Isis Pharmaceuticals to Receive $7.5 Million from Alnylam 4:30 p.m. Jan. 13, 2014 - PR Newswire - PRF
Critical Alerts For GM, Isis Pharmaceuticals, Boston Beer, MasterCard, and Macy's Released By InvestorsObserver 9:31 a.m. Jan. 13, 2014 - PR Newswire - PRF
Upcoming Presentations and Stock Price Movements - Research Report on Bard, Regeneron, Alexion, Seattle Genetics, and Isis Pharmaceuticals 8:00 a.m. Jan. 9, 2014 - PR Newswire
NIH Data Sharing Projects Could Accelerate RNAi Field 11:16 a.m. Jan. 8, 2014 - ACCESSWIRE
Isis Pharmaceuticals to Present at the 32nd Annual J.P. Morgan Healthcare Conference 7:00 a.m. Jan. 6, 2014 - PR Newswire
Market Technicals on Thursday: Quest Diagnostics, Santarus, Isis Pharma, and Community Health Systems 8:00 a.m. Dec. 26, 2013 - PR Newswire
Stock Price Movements of Healthcare Companies- Research Report on LabCorp, Isis Pharmaceuticals, Mindray, Clovis Oncology and Sangamo Biosciences 8:00 a.m. Dec. 23, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Waters Acquires MOBILion: Ion Mobility Meets AI

MOBILion Joins Waters' Fold: A New Era for Proteomics Ah, the biotech world just saw another big whirl with Waters Corporation snagging MOBILion Systems. Now, this isn't just some stroll in the market park. We're talking about weaving MOBILion's fancy high-resolution ion mobility separation tech right into Waters' already robust mass spectrometry setup. These folks are...

PrimeBOT: Breaking Tech Molds with Celeb Backing

Not Your Average Tech Buzz It starts with Hollywood glitz and an unexpected dance partner. The PrimeBOT, a Chinese personal robot, is ditching the drab tech corner and seeping into mainstream culture. Imagine Johnny Depp slapping some paint on this machine alongside local kids. Now, picture the Kardashians casually dining with it, letting it join their lunchtime...

Duke Energy Florida Plans Major Rate Cut for 2027

Slashing Rates to Keep Customers Happy Staring down utility bills isn't anyone's favorite pastime, but there's some good news for folks under Duke Energy Florida's wings. Come January 2027, customers throughout the Sunshine State are in for a surprise on their electricity bills—lower numbers! A $33 slash in the typical residential power bill could be just around the...

Curaleaf Eyes Aurora Amid Alternative from Organigram

Curaleaf's Determined Pursuit of Aurora Another day, another chess move in the cannabis world. Curaleaf is standing tall amid talk of a buyout, putting a foot forward to highlight its determination in the battle for Aurora. They've put forth an alternative to the proposal poised by Organigram, raising stakes and eyebrows alike. Aurora Cannabis is in the middle of a dance...

YR Fitness Rolls Out Innovator's Iron at FIBO 2027

A New Era of Strength Training Equipment? That's the question I asked myself when I heard about YR Fitness showcasing their latest gym gear at FIBO 2027. This isn't just another batch of machines rolling off the production line. YR Fitness has become quite the icon in China for strength equipment, and they're dead set on shaking up the market in Cologne, Germany from...

Lumentum Holders Question Marvell Deal Fairness: Legal Eyes

What's Brewing with Lumentum and Marvell? There's no denying the chatter on Wall Street when there's a potential shake-up, especially with a big merger at stake. We're staring down the barrel of an investigation concerning Lumentum Holdings Inc. (NASDAQ: LITE) and Marvell Technology, Inc.'s deal. The M&A Class Action Firm, helmed by Juan Monteverde, is the name leading...

Midterms Stir Markets; Event Contracts Fuel Q3 Gains

Midterms Mingle with Financial Markets Folks, throw those ballots into the ring, because today the midterms are kicking things off and boy, are they shaking up the game on these prediction markets. Traders and exchanges are on their toes, and the money's flowing like cold brew in July. Robinhood, Intercontinental Exchange, CME Group, and others reported noticeable ripples...

Tokenized Securities: Transfer Online's Next Frontier

Transfer Online Teams Up with OnchainTA Hold onto your investment hats, folks—Transfer Online is linking arms with OnchainTA to step right into the future playground of tokenized securities. Now, what's that mean? Well, it's like jumping from sailing schooners to speedboats; we're entering a whole new era in capital markets. What's At Stake? The pair-up between these...

Swif.ai Paves Linux Path for Enterprise Developers

The Quiet Revolution: Linux Takes Center Stage Linux, once the underdog of operating systems, is gaining significant traction in the world of AI development. It's not just a nerd's sandbox anymore; it's rapidly becoming the go-to platform for cutting-edge AI innovation. Now, more enterprise IT departments are facing the choice of keeping up with Linux's popularity—or...

Xi Jinping's Vision for China's Financial Evolution

Xi's Blueprint for Financial Strength Xi Jinping isn't just whistling Dixie when it comes to reshaping China's financial landscape. His vision is about more than pushing paper; it's about embedding honesty, prudence, and traditional values into the very DNA of China's financial sector. When he talks about enhancing both hard and soft power, he’s thinking wider than...